Status:
COMPLETED
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Brief Summary
This observational study will evaluate the course of treatment, the efficacy on anemia and the safety of Mircera (methoxy polyethylene glycol-epoetin beta) in patients with chronic kidney disease on d...
Eligibility Criteria
Inclusion
- Adult patients, \>/= 18 years of age
- Chronic kidney disease, on dialysis for \> 3 months
- Treatment-naïve or previous treatment with ESA
- Initiation of treatment with Mircera for renal insufficiency associated anemia by decision of the treating physician
Exclusion
- Participation in a clinical trial
- Anemia due to an associated malignant pathology
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
419 Patients enrolled
Trial Details
Trial ID
NCT01213485
Start Date
March 1 2010
End Date
October 1 2011
Last Update
November 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuilly-sur-Seine, France, 92521